ENVECSI
Live / Allowed — Fifth extension granted (statement of use) (as of 03 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Jun 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97463189
- Mark type
- Word mark
- Filed
- 17 Jun 2022
- Published for opposition
- 08 Aug 2023
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; anti-allergics; vaccines
Owner
- JOHNSON & JOHNSON, New Brunswick, NJ, US
- JOHNSON & JOHNSON, New Brunswick, NJ, US
Prosecution history
- 04 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Aug 2026 — SOU EXTENSION 5 GRANTED
- 30 Mar 2026 — SOU EXTENSION 5 FILED
- 03 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 18 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Sept 2025 — SOU EXTENSION 4 GRANTED
- 18 Sept 2025 — SOU EXTENSION 4 FILED
- 18 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2025 — SOU EXTENSION 3 GRANTED
- 27 Mar 2025 — SOU EXTENSION 3 FILED
- 27 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Sept 2024 — SOU EXTENSION 2 GRANTED